Common use of Authorization of Notes Clause in Contracts

Authorization of Notes. The Company will authorize the issue and sale of (i) $18,000,000 aggregate principal amount of its 7.04% Senior Secured Guaranteed Notes, Series A, due August 1, 2008 (the "SERIES A NOTES") and (ii) $9,000,000 aggregate principal amount of its 7.14% Senior Secured Guaranteed Notes, Series B, due August 1, 2010 (the "SERIES B NOTES" and, together with the Series A Notes, the "NOTES," such term to include any such notes issued in substitution for the appropriate series pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Series A Notes shall be substantially in the form set out in Exhibit 1-A and the Series B Notes shall be substantially in the form of Exhibit 1-B, in each case, with such changes therefrom, if any, as may be approved by you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of (ia) $18,000,000 75,000,000 aggregate principal amount of its 7.043.70% Senior Secured Guaranteed Notes, Series A, due August 1November 30, 2008 2030 (the "SERIES “Series A NOTES"Notes”) and (iib) $9,000,000 55,000,000 aggregate principal amount of its 7.143.82% Senior Secured Guaranteed Notes, Series B, due August 1November 30, 2010 2031 (the "SERIES “Series B NOTES" andNotes”, and together with the Series A Notes, the "NOTES," such term “Notes”, each as amended, restated or otherwise modified from time to include time pursuant to Section 17 and including any such notes issued in substitution for the appropriate series therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)13). The Series A Notes shall be substantially in the form forms set out in Exhibit Schedule 1-A and the Series B Notes shall be substantially in the form of Exhibit 1-B, in each case, with such changes therefrom, if any, as may be approved by you and the Companyrespectively. Certain capitalized and other terms used in this Agreement are defined in Schedule B; B. References to “series” of Notes shall refer to the Series A Notes and the Series B Notes or all, as the context may require. References to a “Schedule” are references to a "Schedule" or an "Exhibit" are, Schedule attached to this Agreement unless otherwise specified, . References to a Schedule or an Exhibit attached “Section” are references to a Section of this AgreementAgreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of (ia) U.S. $18,000,000 71,500,000 aggregate principal amount of its 7.044.67% Senior Secured Guaranteed Notes, Series A, due August 1May 11, 2008 2015 (the "SERIES “Series A NOTES"Notes”) and (iib) $9,000,000 U.S. $ 115,500,000 aggregate principal amount of its 7.145.98% Senior Secured Guaranteed Notes, Series B, due August 1May 11, 2010 2020 (the "SERIES “Series B NOTES" and, together with Notes”; the Series A Notes and Series B Notes being hereinafter collectively referred to as the “Notes”, the "NOTES," such term to include any such notes issued in substitution for the appropriate series therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Series A Notes shall be substantially in the form set out in Exhibit 1-A and 1 or Exhibit 2, as the Series B Notes shall be substantially in the form of Exhibit 1-B, in each casecase may be, with such changes therefrom, if any, as may be approved by you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "“Section,” “Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Section of, or a Schedule or an Exhibit attached to to, this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of (i) $18,000,000 70,000,000 aggregate principal amount of its 7.043.58% Series A Senior Secured Guaranteed NotesNotes due March 13, Series A, due August 1, 2008 2024 (the "SERIES “Series A NOTES"Notes”) and (ii) $9,000,000 55,000,000 aggregate principal amount of its 7.144.61% Series B Senior Secured Guaranteed NotesNotes due March 13, Series B, due August 1, 2010 2044 (the "SERIES “Series B NOTES" and, Notes,” together with the Series A Notes, the "NOTES“Notes," such ” the term to Notes shall also include any such notes issued in substitution for the appropriate series Series A Notes or the Series B Notes, as the case may be, pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)Agreement). The Series A Notes shall be substantially in the form set out in Exhibit 1-A and the Series B Notes shall be substantially in the form of Exhibit 1-B, in each case, with such changes therefrom, if any, as may be approved by you the Purchasers and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of (i) $18,000,000 50,000,000 aggregate principal amount of its 7.042.82% Series A Senior Secured Guaranteed NotesNotes due April 15, Series A, due August 1, 2008 2025 (the "SERIES “Series A NOTES"Notes”) and (ii) $9,000,000 100,000,000 aggregate principal amount of its 7.143.66% Series B Senior Secured Guaranteed NotesNotes due April 15, Series B, due August 1, 2010 2045 (the "SERIES “Series B NOTES" and, Notes,” together with the Series A Notes, the "NOTES“Notes," such ” the term to Notes shall also include any such notes issued in substitution for the appropriate series Series A Notes or the Series B Notes, as the case may be, pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)Agreement). The Series A Notes shall be substantially in the form set out in Exhibit 1-A and the Series B Notes shall be substantially in the form of Exhibit 1-B, in each case, with such changes therefrom, if any, as may be approved by you the Purchasers and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of (i) $18,000,000 100,000,000 aggregate principal amount of its 7.04% Senior Secured Guaranteed Notessenior notes, Series A, due August 1, 2008 (the "SERIES A NOTES") and (ii) of which $9,000,000 50,000,000 aggregate principal amount of shall be its 7.143.73% Series A Senior Secured Guaranteed NotesNotes due April 15, Series B, due August 1, 2010 2023 (the "SERIES “Series A Notes”) and $50,000,000 aggregate principal amount shall be its 3.88% Series B NOTES" andSenior Notes due April 15, together with 2025 (the “Series B Notes”) (the Series A Notes and the Series B Notes, the "NOTES," such term as amended, restated or otherwise modified from time to include time pursuant to Section 17 and including any such notes issued in substitution for the appropriate series therefor pursuant to Section 13 of this Agreement or 13, each a “Note” and collectively, the Other Agreements (as hereinafter defined)“Notes”). The Series A Notes shall be substantially in the form respective forms set out in Exhibit 1-A Exhibits 1(a) and the Series B Notes shall be substantially in the form of Exhibit 1-B, in each case, with such changes therefrom, if any, as may be approved by you and the Company1(b). Certain capitalized and other terms used in this Agreement are defined in Schedule B; references B. References to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of (i) $18,000,000 100,000,000 aggregate principal amount of its 7.04% Senior Secured Guaranteed Notes, Series A, due August 1, 2008 senior notes consisting of (the "SERIES A NOTES") and (iia) $9,000,000 50,000,000 aggregate principal amount of its 7.142.97% Senior Secured Guaranteed Notes, Series B2021A, due August 1October 30, 2010 2051 (the "SERIES “Series A Notes”) and (b) $50,000,000 aggregate principal amount of its 3.07% Senior Notes, Series 2021B, due October 28, 2061 (the “Series B NOTES" and, Notes” and together with the Series A Notes, the "NOTES," “Notes” such term to shall also include any such notes Series A Notes or Series B Notes issued in substitution for the appropriate series therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)Agreement). The Series A Notes and the Series B Notes shall be substantially in the form set out in Exhibit 1-A 1(a) and the Series B Notes shall be substantially in the form of Exhibit 1-B1(b), in each caserespectively, with such changes therefrom, if any, as may be approved by you the Purchasers and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of (ia) $18,000,000 100,000,000 aggregate principal amount of its 7.042.41% Senior Secured Guaranteed Green Notes, Series A, due August 1July 15, 2008 2028 (the "SERIES “Series A NOTES"Notes”) and (iib) $9,000,000 50,000,000 aggregate principal amount of its 7.142.84% Senior Secured Guaranteed Notes, Series B, due August 1July 15, 2010 2031 (the "SERIES “Series B NOTES" andNotes”, together with the Series A Notes, the "NOTES“Notes," ” such term to include any such notes as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution for the appropriate series therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)13). The Series A Notes shall be substantially in the form forms set out in Exhibit 1-A Schedule 1(a) and the Series B Notes shall be substantially in the form of Exhibit 1-BSchedule 1(b), in each caserespectively, with such changes therefrom, if any, as may be approved by you the Purchasers and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; A. References to a “Schedule” are references to a "Schedule" or an "Exhibit" are, Schedule attached to this Agreement unless otherwise specified, . References to a Schedule or an Exhibit attached “Section” are references to a Section of this Agreement.Agreement unless otherwise specified. Terreno Realty LLC Agreement Note Purchase

Authorization of Notes. The Company will authorize the issue and sale of (i) $18,000,000 100,000,000 aggregate principal amount of its 7.04% Senior Secured Guaranteed Notes, Series A, due August 1, 2008 senior notes consisting of (the "SERIES A NOTES") and (iia) $9,000,000 50,000,000 aggregate principal amount of its 7.145.56% Senior Secured Guaranteed Notes, Series B2023A, due August 1September 28, 2010 2033 (the "SERIES “Series A Notes”) and (b) $50,000,000 aggregate principal amount of its 5.85% Senior Notes, Series 2023B, due October 30, 2053 (the “Series B NOTES" and, Notes”; and together with the Series A Notes, the "NOTES," “Notes” such term to shall also include any such notes Series A Notes or Series B Notes issued in substitution for the appropriate series therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)Agreement). The Series A Notes and Series B Notes shall be substantially in the form set out in Exhibit 1-A and the Series B Notes shall be substantially in the form of 1(a) or Exhibit 1-B1(b), in each caserespectively, with such changes therefrom, if any, as may be approved by you the Purchasers and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of of: (i) $18,000,000 125,000,000 aggregate principal amount of its 7.043.49% Senior Secured Guaranteed Notes, Series A, due August 115, 2008 2025 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the "SERIES “Series A NOTES") and Notes”), (ii) $9,000,000 75,000,000 aggregate principal amount of its 7.144.06% Senior Secured Guaranteed Notes, Series B, due August 115, 2010 2033 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the "SERIES “Series B NOTES" Notes”), and (iii) $150,000,000 aggregate principal amount of its 4.74% Senior Notes, Series C, due August 15, 2043 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Series C Notes” and, together with the Series A Notes and the Series B Notes, the "NOTES," such term to include any such notes issued in substitution for the appropriate series pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)“Notes”). The Series A Notes shall be substantially in the form respective forms set out in Exhibit Schedule 1-A , Schedule 2, and the Series B Notes shall be substantially in the form of Exhibit 1-B, in each case, with such changes therefrom, if any, as may be approved by you and the CompanySchedule 3. Certain capitalized and other terms used in this Agreement are defined in Schedule B; A. References to a “Schedule” are references to a "Schedule" or an "Exhibit" are, Schedule attached to this Agreement unless otherwise specified, . References to a Schedule or an Exhibit attached “Section” are references to a Section of this AgreementAgreement unless otherwise specified.

Authorization of Notes. The Company Issuer will authorize the issue and sale of (i) $18,000,000 275,000,000 aggregate principal amount of its 7.042.80% Senior Secured Guaranteed Notes, Series A, due August 1September 29, 2008 2031 (the "SERIES “Series A NOTES"Notes”) and (ii) $9,000,000 50,000,000 aggregate principal amount of its 7.142.95% Senior Secured Guaranteed Notes, Series B, due August 1September 28, 2010 2033 (the "SERIES “Series B NOTES" and, Notes,” together with the Series A Notes, the "NOTES," “Notes”, such term to include any amendments, restatements or modifications from time to time pursuant to Section 17 and including any such notes issued in substitution for the appropriate series therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)13). The Series A Notes shall be substantially in the form set out in Exhibit 1-A and the Series B Notes shall be substantially in the form of Exhibit 1-Bset out in Schedule 1(a) and Schedule 1(b), in each case, with such changes therefrom, if any, as may be approved by you and the Companyrespectively. Certain capitalized and other terms used in this Agreement are defined in Schedule B; A. References to a “Schedule” are references to a "Schedule" or an "Exhibit" are, Schedule attached to this Agreement unless otherwise specified, . References to a Schedule “Section” are references to a Section of this Agreement unless otherwise specified. References to “Series” of Notes shall refer to the Series A Notes and the Series B Notes, or an Exhibit attached to this Agreementboth, as the context may require.

Authorization of Notes. The Company will authorize the issue and sale of (ia) $18,000,000 50,000,000 aggregate principal amount of its 7.044.23% Senior Secured Guaranteed Notes, Series A, A due August September 1, 2008 2022 (the "SERIES “Series A NOTES"Notes”) and (iib) $9,000,000 50,000,000 aggregate principal amount of its 7.144.65% Senior Secured Guaranteed Notes, Series BB due October 13, due August 1, 2010 2027 (the "SERIES “Series B NOTES" and, Notes” and together with the Series A Notes, the "NOTES," such term to include any such notes as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution for the appropriate series therefor pursuant to Section 13 of this Agreement or 13, the Other Agreements (as hereinafter defined)“Notes”). The Series A Notes shall be substantially in the form set out in Exhibit 1-A and the Series B Notes shall be substantially in the form of Exhibit set out in Schedule 1-A and Schedule 1-B, in each case, with such changes therefrom, if any, as may be approved by you and the Companyrespectively. Certain capitalized and other terms used in this Agreement are defined in Schedule B; A. References to a “Schedule” are references to a "Schedule" or an "Exhibit" are, Schedule attached to this Agreement unless otherwise specified, . References to a Schedule or an Exhibit attached “Section” are references to a Section of this AgreementAgreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of (i) $18,000,000 150,000,000 aggregate principal amount of its 7.04% Senior Secured Guaranteed Notes, Series A, due August 1, 2008 senior notes consisting of (the "SERIES A NOTES") and (iia) $9,000,000 100,000,000 aggregate principal amount of its 7.143.76% Senior Secured Guaranteed Notes, Series B2019A, due August 1July 17, 2010 2049 (the "SERIES B NOTES" and, together with the “Series A Notes”) and (b) $85,000,000 aggregate principal amount of its 3.86% Senior Notes, Series 2019B, due July 17, 2059 (the "NOTES," “Series B Notes”). The Series A Notes and the Series B Notes are herein collectively referred to as the “Notes” (such term to shall also include any such notes issued in substitution for the appropriate series any such Series A Notes or Series B Notes pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)Agreement). The Series A Notes and Series B Notes shall be substantially in the form set out in Exhibit 1-A 1(a) and the Series B Notes shall be substantially in the form of Exhibit 1-B1(b), in each caserespectively, with such changes therefrom, if any, as may be approved by you the Purchasers and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company Issuer will authorize the issue and sale of (ia) $18,000,000 200,000,000 aggregate principal amount of its 7.044.11% Series A Senior Secured Guaranteed Notes due April 17, 2026 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Series A Notes, Series A, due August 1, 2008 (the "SERIES A NOTES"”) and (iib) $9,000,000 200,000,000 aggregate principal amount of its 7.144.31% Series B Senior Secured Guaranteed Notes due April 17, 2029 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Series B Notes, Series B, due August 1, 2010 (the "SERIES B NOTES" ,” and, together with the Series A Notes, collectively, the "NOTES," such term to include any such notes issued in substitution for the appropriate series pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)“Notes”). The Series A Notes shall be substantially in the form set out in Exhibit 1-A Schedule 1.1(a) and the Series B Notes shall be substantially in the form of Exhibit 1-B, set out in each case, with such changes therefrom, if any, as may be approved by you and the CompanySchedule 1.1(b). Certain capitalized and other terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" areA and, unless otherwise specified, to a Schedule or an Exhibit attached to for purposes of this Agreement, the rules of construction set forth in Section 22.4 shall govern.

Authorization of Notes. The Company will authorize the issue and sale of (ia) $18,000,000 U.S.$10,000,000 aggregate principal amount of its 7.045.71% Series A Senior Secured Guaranteed NotesNotes due June 15, Series A, due August 1, 2008 2010 (the "SERIES “Series A NOTES"Notes”) and (iib) U.S. $9,000,000 55,000,000 aggregate principal amount of its 7.146.16% Series B Senior Secured Guaranteed NotesNotes due June 15, Series B, due August 1, 2010 2013 (the "SERIES “Series B NOTES" and, Notes”; said Series B Notes together with the Series A Notes being hereinafter collectively referred to as the “Notes, the "NOTES," ” such term to include any such notes issued in substitution for the appropriate series therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)Agreement). The Series A Notes and Series B Notes shall be substantially in the form set out in Exhibit 1-A 1(a) and the Series B Notes shall be substantially in the form of Exhibit 1-B1(b), in each caserespectively, with such changes therefrom, if any, as may be approved by you the Purchasers and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company Issuer will authorize the issue and sale of (i) $18,000,000 100,000,000 aggregate principal amount of its 7.044.12% Senior Secured Guaranteed Notes, Series A, due August 1June 30, 2008 2021 (the "SERIES “Series A NOTES"Notes”) and (ii) $9,000,000 150,000,000 aggregate principal amount of its 7.144.58% Senior Secured Guaranteed Notes, Series B, due August 1June 30, 2010 2024 (the "SERIES “Series B NOTES" and, together with Notes”). The Series A Notes and the Series A B Notes are collectively referred to herein as the “Notes, the "NOTES," ” such term to include any amendments, restatements or other modifications from time to time pursuant to Section 17 and including any such notes issued in substitution for the appropriate series therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined))13. The Series A Notes shall be substantially in the form set out in Exhibit 1-A and the Series B Notes shall be substantially in the form of Exhibit 1-Bset out in Schedule 1(a) and Schedule 1(b), in each case, with such changes therefrom, if any, as may be approved by you and the Companyrespectively. Certain capitalized and other terms used in this Agreement are defined in Schedule B; A. References to a “Schedule” are references to a "Schedule" or an "Exhibit" are, Schedule attached to this Agreement unless otherwise specified, . References to a Schedule or an Exhibit attached “Section” are references to a Section of this AgreementAgreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of (i) $18,000,000 25,000,000 aggregate principal amount of its 7.044.13% Senior Secured Guaranteed Notes, Series A, due August 1December 21, 2008 2022 (the "SERIES “Series A NOTES") and Notes”), (ii) $9,000,000 30,000,000 aggregate principal amount of its 7.144.57% Senior Secured Guaranteed Notes, Series B, due August 1December 21, 2010 2027 (the "SERIES “Series B NOTES" andNotes”), and (iii) $20,000,000 aggregate principal amount of its 4.72% Senior Guaranteed Notes, Series C, due December 21, 2029 (the “Series C Notes”, and together with the Series A and Series B Notes, the "NOTES," such term “Notes”, each as amended, restated or otherwise modified from time to include time pursuant to Section 17 and including any such notes issued in substitution for the appropriate series therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)13). The Series A Notes shall be substantially in the form set out in Exhibit 1-A and the Series B Notes shall be substantially in the form of Exhibit 1-BSchedule 1A, in each case, with such changes therefrom, if any, as may be approved by you and the CompanySchedule 1B or Schedule 1C respectively. Certain capitalized and other terms used in this Agreement are defined in Schedule B; B. References to a “Schedule” are references to a "Schedule" or an "Exhibit" are, Schedule attached to this Agreement unless otherwise specified, . References to a Schedule “Section” are references to a Section of this Agreement unless otherwise specified. References to “series” of Notes shall refer to the Series A Notes, the Series B Notes or an Exhibit attached to this AgreementSeries C Notes, as the context may require.

Authorization of Notes. The Company will authorize the issue and sale of (i) $18,000,000 200,000,000 aggregate principal amount of its 7.04% Senior Secured Guaranteed Notes, Series A, due August 1, 2008 senior notes consisting of (the "SERIES A NOTES") and (iia) $9,000,000 125,000,000 aggregate principal amount of its 7.145.82% Senior Secured Guaranteed Notes, Series B2024A, due August 1June 26, 2010 2054 (the "SERIES “Series A Notes”) and (b) $75,000,000 aggregate principal amount of its 5.49% Senior Notes, Series 2024B, due September 30, 2034 (the “Series B NOTES" and, Notes”; and together with the Series A Notes, the "NOTES," “Notes” such term to shall also include any such notes Series A Notes or Series B Notes issued in substitution for the appropriate series therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)Agreement). The Series A Notes and Series B Notes shall be substantially in the form set out in Exhibit 1-A and the Series B Notes shall be substantially in the form of 1(a) or Exhibit 1-B1(b), in each caserespectively, with such changes therefrom, if any, as may be approved by you the Purchasers and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of (i) $18,000,000 75,000,000 aggregate principal amount of its 7.04% Senior Secured Guaranteed Notes, Series A, due August 1, 2008 senior notes consisting of (the "SERIES A NOTES") and (iia) $9,000,000 25,000,000 aggregate principal amount of its 7.142.87% Senior Secured Guaranteed Notes, Series B2020D, due August September 1, 2010 2050 (the "SERIES B NOTES" and“Series D Notes”) and (b) $50,000,000 aggregate principal amount of its 2.97% Senior Notes, Series 2020E, due September 1, 2060 (the “Series E Notes” and together with the Series A D Notes, the "NOTES," “Notes” such term to shall also include any such notes Series D Notes or Series E Notes issued in substitution for the appropriate series therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)Agreement). The Series A D Notes and the Series E Notes shall be substantially in the form set out in Exhibit 1-A 1(a) and the Series B Notes shall be substantially in the form of Exhibit 1-B1(b), in each caserespectively, with such changes therefrom, if any, as may be approved by you the Purchasers and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of (i) $18,000,000 125,000,000 aggregate principal amount of its 7.043.99% Series A Senior Secured Guaranteed Notes due January 13, 2023 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Series A Notes, Series A, due August 1, 2008 (the "SERIES A NOTES"”) and (ii) $9,000,000 100,000,000 aggregate principal amount of its 7.144.51% Series B Senior Secured Guaranteed Notes due January 13, 2027 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Series B Notes, Series B, due August 1, 2010 (the "SERIES B NOTES" and, ”; and together with the Series A Notes, the "NOTES," such term to include any such notes issued in substitution for the appropriate series pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)“Notes”). The Series A Notes shall be substantially in the form set out in Exhibit 1-A and the Series B Notes shall be substantially in the form of Exhibit 1-Bset out in Schedule 1(a) and Schedule 1(b), in each case, with such changes therefrom, if any, as may be approved by you and the Companyrespectively. Certain capitalized and other terms used in this Agreement are defined in Schedule B; A. References to a “Schedule” are references to a "Schedule" or an "Exhibit" are, Schedule attached to this Agreement unless otherwise specified, . References to a Schedule or an Exhibit attached “Section” are references to a Section of this AgreementAgreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of (i) $18,000,000 100,000,000 aggregate principal amount of its 7.04% Senior Secured Guaranteed Notes, Series A, due August 1, 2008 senior notes consisting of (the "SERIES A NOTES") and (iia) $9,000,000 50,000,000 aggregate principal amount of its 7.144.37% Senior Secured Guaranteed Notes, Series B2022A, due August 1May 27, 2010 2037 (the "SERIES “Series A Notes”) and (b) $50,000,000 aggregate principal amount of its 4.71% Senior Notes, Series 2022B, due May 27, 2052 (the “Series B NOTES" and, Notes” and together with the Series A Notes, the "NOTES," “Notes” such term to shall also include any such notes Series A Notes or Series B Notes issued in substitution for the appropriate series therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)Agreement). The Series A Notes and the Series B Notes shall be substantially in the form set out in Exhibit 1-A 1(a) and the Series B Notes shall be substantially in the form of Exhibit 1-B1(b), in each caserespectively, with such changes therefrom, if any, as may be approved by you the Purchasers and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement. References to a “Section” are references to a Section of this Agreement unless otherwise specified.